Crispr Therapeutics Ag (CRSP)

R&D Expenses

$270.29M

TTM · Period ending: · USD

CRSP logo

CRSP R&D Expenses

Latest reported$270.29M
CRSP R&D Expenses ($1.51M → $270.29M)
High-resolution chart · PNG

CRSP r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
265,327,000
320,653,000
387,332,000
461,645,000
340,567,000
221,382,000
179,362,000
113,773,000
69,800,000
42,238,000
12,573,000
1,513,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.